Long-Term Effects of the Collagenase of the Bacterium Clostridium histolyticum for the Treatment of Capsular Fibrosis After Silicone Implants

[1]  B. Pomahac,et al.  The Collagenase of the Bacterium Clostridium histolyticum for the Treatment of Capsular Fibrosis after Silicone Implants , 2015, Plastic and reconstructive surgery.

[2]  R. Freitas,et al.  Prevention of Capsular Contracture Using Leukotriene Antagonists , 2015, Plastic and reconstructive surgery.

[3]  Jonathan L Rees,et al.  Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator cuff repair [the UK Rotator Cuff Surgery (UKUFF) randomised trial]. , 2015, Health technology assessment.

[4]  C. Robertson,et al.  Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation. , 2015, Health technology assessment.

[5]  Taylor C Peak,et al.  Role of collagenase clostridium histolyticum in Peyronie’s disease , 2015, Biologics : targets & therapy.

[6]  W. Hellstrom,et al.  Collagenase Clostridium histolyticum (Xiaflex) for the Treatment of Urethral Stricture Disease in a Rat Model of Urethral Fibrosis. , 2015, Urology.

[7]  B. Pomahac,et al.  Silicone Implants with Smooth Surfaces Induce Thinner but Denser Fibrotic Capsules Compared to Those with Textured Surfaces in a Rodent Model , 2015, PloS one.

[8]  R. Gerber,et al.  Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture , 2015, The Journal of hand surgery, European volume.

[9]  Ziyad S. Hammoudeh.  Collagenase Clostridium histolyticum injection for plantar fibromatosis (Ledderhose disease). , 2014, Plastic and reconstructive surgery.

[10]  E. Akelman,et al.  Surgical findings in the treatment of Dupuytren’s disease after initial treatment with clostridial collagenase (Xiaflex) , 2014, The Journal of hand surgery, European volume.

[11]  R. Gurunluoglu,et al.  Outcomes Analysis of Patients Undergoing Autoaugmentation after Breast Implant Removal , 2013, Plastic and reconstructive surgery.

[12]  I. Goldstein,et al.  Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. , 2013, The Journal of urology.

[13]  P. Sengupta.  The Laboratory Rat: Relating Its Age With Human's , 2013, International journal of preventive medicine.

[14]  L. Lipshultz,et al.  Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease. , 2012, The Journal of urology.

[15]  M. Freshwater.  What were the adverse events for Dupuytren’s patients treated with Xiaflex who had contractures less than 20°? , 2012, Hand.

[16]  A. Bayat,et al.  In Vitro Study of Novel Collagenase (XIAFLEX®) on Dupuytren's Disease Fibroblasts Displays Unique Drug Related Properties , 2012, PloS one.

[17]  A. Bayat,et al.  The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease , 2010, Therapeutics and clinical risk management.

[18]  C. Schwentner,et al.  The immunology of fibrosis: innate and adaptive responses. , 2010, Trends in immunology.

[19]  V. Hentz,et al.  Injectable collagenase clostridium histolyticum for Dupuytren's contracture. , 2009, The New England journal of medicine.

[20]  G. Gravante,et al.  Capsular Contractures: A Systematic Review , 2009, Plastic and reconstructive surgery.

[21]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[22]  L. Hurst,et al.  Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. , 2007, The Journal of hand surgery.

[23]  J. A. Jensen,et al.  A Long-Term Study of Outcomes, Complications, and Patient Satisfaction with Breast Implants , 2006, Plastic and reconstructive surgery.

[24]  Andrew Leask,et al.  TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  V. Hentz,et al.  Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. , 2002, The Journal of hand surgery.

[26]  D. Sharpe,et al.  Recurrence of Subglandular Breast Implant Capsular Contracture: Anterior versus Total Capsulectomy , 2000, Plastic and reconstructive surgery.

[27]  Young Vl.  Guidelines and indications for breast implant capsulectomy. , 1998 .

[28]  H. Murata,et al.  TGF-β3 stimulates and regulates collagen synthesis through TGF-β1- dependent and independent mechanisms , 1997 .

[29]  R. Dowden,et al.  Radiation Therapy as a Cause of Capsular Contracture , 1994, Annals of plastic surgery.

[30]  G. Mikuz,et al.  Tissue reactions from silicone implant in augmentation mammaplasties. , 1983, Minerva chirurgica.

[31]  L. Levine,et al.  Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study. , 2015, The journal of sexual medicine.

[32]  L. Levine,et al.  Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment. , 2015, The journal of sexual medicine.

[33]  M. Dobke.  Subclinical (Biofilm) Infection Causes Capsular Contracture in a Porcine Model following Augmentation Mammaplasty , 2012 .

[34]  D. Zelouf.  Injectable Collagenase Clostridium Histolyticum: A New Nonsurgical Treatment for Dupuytren's Disease , 2011 .

[35]  J. Kaufman,et al.  Collagenase for Peyronie's disease experimental studies , 2004, Urological Research.

[36]  H. Murata,et al.  TGF-beta3 stimulates and regulates collagen synthesis through TGF-beta1-dependent and independent mechanisms. , 1997, The Journal of investigative dermatology.

[37]  L. Hurst,et al.  Enzyme Injection as a Nonoperative Treatment for Dupuytren's Disease , 1996 .